Compare MUSA & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MUSA | RDY |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.6B |
| IPO Year | 2013 | 2001 |
| Metric | MUSA | RDY |
|---|---|---|
| Price | $530.45 | $13.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $485.57 | $16.90 |
| AVG Volume (30 Days) | 304.1K | ★ 2.7M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | 0.49% | ★ 0.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $21,529,400,000.00 | N/A |
| Revenue This Year | $19.47 | $7.72 |
| Revenue Next Year | $2.37 | $3.50 |
| P/E Ratio | $74.75 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $345.23 | $12.19 |
| 52 Week High | $609.82 | $16.17 |
| Indicator | MUSA | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 42.88 | 56.00 |
| Support Level | $366.48 | $12.90 |
| Resistance Level | $609.82 | $14.04 |
| Average True Range (ATR) | 21.04 | 0.26 |
| MACD | -8.35 | 0.06 |
| Stochastic Oscillator | 6.45 | 92.98 |
Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.